Thus, 500 patients with invasive breast cancer, previously reported in a study,11 were divided into three groups (high, intermediate, and low HER2‐AAb groups) depending on two cutoffs: log‐transformed HER2‐AAb concentrations at mean +2SD and mean –2SD of the healthy control. The gene discussed is ERBB2; the disease is invasive breast carcinoma.